Coagulation Markers Market Outlook (2023 to 2033)

The coagulation markers market size is projected to be worth USD 1.21 billion in 2023. The market is likely to surpass USD 2.22 billion by 2033 at a CAGR of 6.3% during the forecast period. Growing surgical orthopedic procedures, such as venous thromboembolism (VTE), have resulted in a market increase.

According to several studies on preoperative risk assessment, the majority of patients undergoing major orthopedic surgery would be hypercoagulable. The use of coagulation markers in the screening of VTE has proven to be quite successful in detecting coagulation activation.

Other Drivers Propelling the Demand for Coagulation Markers include:

  • The rising prevalence of Ischemic Stroke is driving market expansion. According to the WHO Global Stroke Factsheet produced in 2022, the lifetime risk of getting a stroke has increased by 50%. Coagulation markers can detect coagulation system activity in stroke patients, which is helping to meet the growing need.
  • Persistent coagulation abnormalities appear to increase the likelihood of a wide range of non-AIDS-defining consequences. Several studies found that plasma D-dimer levels, a fibrinolysis marker, independently predicted morbidity in HIV-infected individuals. These factors assist to market growth.
  • Coagulation indicators are critical in identifying individuals who may benefit from certain treatment measures, such as genetically tailored anticoagulant dose. Precision therapies seek to improve efficacy while minimizing side effects by optimizing treatment options based on an individual's coagulation marker profile.

Challenges for Companies /Manufacturers in the Coagulation Markers Market:

  • Many coagulation indicators are not disease- or condition-specific. Marker levels can be elevated or lowered in many coagulation diseases, making it difficult to establish the specific reason.
  • Coagulation markers give a snapshot of this dynamic system, but understanding the interaction of numerous components is required for interpretation. Interactions between several indicators and their diagnostic relevance might be complex, making interpretation difficult.
  • Coagulation markers may have unique detection time requirements. D-dimer levels, for example, may not be enhanced immediately after the commencement of a thrombotic episode, necessitating optimal testing time.

Opportunities in the Coagulation Markers Industry:

  • Coagulation indicators can help in the early identification of coagulation problems, allowing for the beginning of treatment and management to begin as soon as possible. Healthcare practitioners can analyze an individual's risk profile and establish personalized preventative treatments by identifying particular indicators linked with thrombotic or bleeding tendencies.
  • Coagulation indicators can be used with other diagnostic modalities, such as imaging or genetic testing, to offer a more complete picture of coagulation diseases. Combining several markers and diagnostic techniques can improve diagnosis accuracy, help with treatment decisions, and make patient management easier.
  • Coagulation markers have the potential to develop personalized treatment in the field of coagulation diseases. Through marker analysis, healthcare practitioners may personalize treatment plans for individuals who may benefit from various therapeutic measures by understanding an individual's coagulation profile.

Latest Trends in the Coagulation Markers Market:

  • There is considerable interest in creating coagulation marker tests that may be used at the point of care, such as at the bedside or in outpatient settings. A major trend in the area is the development of portable and user-friendly coagulation marker testing instruments, which is increasing access to diagnostics in a variety of healthcare settings.
  • Collaboration between researchers, doctors, and regulatory agencies is critical for progressing coagulation marker research and encouraging standardized practices. To increase the reliability and comparability of coagulation marker results, collaborative networks promote data sharing, information exchange, and consensus-building.
Attributes Details
Coagulation Markers Market Size (2023) USD 1.21 billion
Coagulation Markers Market Projected Size (2033) USD 2.22 billion
Value CAGR (2023 to 2033) 6.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2012 to 2022 Coagulation Markers Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global coagulation markers market experienced a CAGR of 3.5%, reaching a market size of USD 1.21 billion in 2023. The increased frequency of coagulation diseases such as DVT, PE, and hemophilia has been a key driver for the coagulation markers industry. Because these illnesses are associated with anomalies in blood coagulation, there is a rising demand for coagulation indicators for diagnostic and monitoring purposes.

Increasing identification and diagnosis of coagulation abnormalities has resulted from increasing awareness of these illnesses, as well as enhanced diagnostic skills. Because healthcare personnel are now better trained to diagnose coagulation abnormalities, coagulation indicators are being used for diagnostic purposes. Early identification and management can enhance patient outcomes, propelling the industry forward.

Future Forecast for Coagulation Markers Industry:

Looking ahead, the global coagulation markers industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 2.22 billion.

The coagulation markers industry is expected to continue its growth trajectory from 2023 to 2033. Continuous technological improvements, such as the development of innovative assays, point-of-care testing devices, and high-throughput automated analyzers, will fuel market expansion. These developments will increase the sensitivity, accuracy, and efficiency of coagulation marker testing, resulting in improved diagnostic capabilities and simpler processes.

The rise of personalized medicine and tailored therapeutics will drive up demand for coagulation indicators. By analyzing coagulation indicators, healthcare practitioners may personalize treatment strategies based on an individual's unique coagulation profile, improving therapeutic results while reducing the risk of bleeding or thrombotic events.

Country-Wise Insights

Coagulation Markers Market to Surge in the United States amid Increasing Prevalence of Coagulation Disorders

Country The United States
Market Size (USD billion) by End of Forecast Period (2033) USD 731.3 million
CAGR % 2023 to End of Forecast (2033) 7.3%

The coagulation markers industry in the United States is expected to reach a market value of USD 731.3 million by 2033, expanding at a CAGR of 7.3%. The United States continues to experience rapid growth in market due to increasing prevalence of coagulation disorders. The prevalence of coagulation diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other thrombotic illnesses has increased in the United States. As a result, there is a greater need for coagulation indicators for the early identification, diagnosis, and monitoring of these illnesses.

Rising Aging Population to Propel the United Kingdom Market Growth.

Country The United Kingdom
Market Size (USD billion) by End of Forecast Period (2033) USD 160.8 million
CAGR % 2023 to End of Forecast (2033) 9.4%

The coagulation markers industry in the United Kingdom is expected to reach a market value of USD 160.8 million, expanding at a CAGR of 9.4% during the forecast period. The United Kingdom market is projected to experience growth owing to the rising aging population. The United Kingdom has an ageing population, with an increasing number of older people. Advanced age increases the risk of coagulation diseases such atrial fibrillation, venous thromboembolism, and stroke. Coagulation marker testing is becoming more popular as the population ages in order to determine the risk of thrombotic events and guide anticoagulant medication.

China's Expansion and Prioritization of Research and Development will lead to Market Growth in the Country.

Country China
Market Size (USD billion) by End of Forecast Period (2033) USD 276.6 million
CAGR % 2023 to End of Forecast (2033) 9.0%

The coagulation markers industry in China is anticipated to reach a market value of USD 276.6 million, moving at a CAGR of 9.0% during the forecast period. The coagulation markers industry in China is expected to grow prominently due to the increasing research and development. The long-term socioeconomic growth of China is being centered on scientific and technical innovation, which the Chinese government is promoting through financing, reform, and societal prestige. China's 14th five-year plan (2021-2025) is focused on pursuing innovation-driven growth and aims for research and development investment to expand by more than 7% annually over that time.

The top scientific magazine, Nature Index 2020 Annual Tables, reports that China's contribution to worldwide natural science research climbed by 15% in 2020. The country's favorable environment ensures that the advances in research production witnessed in previous years will continue.

Rigorous Research and Development Efforts Have Led Japan to Develop and Innovate Novel Coagulation Markers.

Country Japan
Market Size (USD billion) by End of Forecast Period (2033) USD 127.3 million
CAGR % 2023 to End of Forecast (2033) 6.6%

The coagulation markers industry in Japan is estimated to reach a market value of USD 127.3 million by 2033, thriving at a CAGR of 6.6%. The market in Japan is predicted to grow because of the growing demand for novel therapies. Ongoing research and development activities focusing on the development of novel coagulation markers, enhanced testing procedures, and customized assays for the Japanese population have aided market expansion. Collaborations among pharmaceutical firms, research institutes, and healthcare providers foster innovation and the development of enhanced coagulation marker testing.

Demand for Coagulation Markers Market is Rising Due to Strong Healthcare Infrastructure.

Country South Korea
Market Size (USD billion) by End of Forecast Period (2033) USD 74.1 million
CAGR % 2023 to End of Forecast (2033) 5.9%

The coagulation markers industry in South Korea is expected to reach a market value of USD 74.1 million, expanding at a CAGR of 5.9% during the forecast period. The market in South Korea is forecasted to witness growth due to the high healthcare expenditure. South Korea spends a lot on healthcare, and the investment in diagnostics and laboratory testing is growing. Coagulation marker tests are an essential aspect of diagnosing coagulation disorders. Coagulation markers market expansion is further aided by the availability of healthcare insurance coverage and reimbursement policies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-Wise Insights

D-dimer Assay to Dominate Coagulation Markers Industry with 5.4% CAGR through 2033

The D-dimer assay is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. By-products of blood coagulation and breakdown, such as the D-dimer, can be detected via analysis of a blood sample. D-dimer is produced when a blood clot starts to dissolve. This explains why D-dimer test has a large market share.

When a doctor suspects that anything other than DVT or PE is the cause of the symptoms, D-dimer is extremely helpful. It is an efficient, non-invasive method to assist in ruling out irregular or excessive clotting as the underlying reason.

How the Plasma Is Driving the Coagulation Markers Market?

The plasma is expected to dominate the coagulation markers industry with a CAGR of 6.2% from 2022 to 2033.

Since plasma has a high quantity of fibrinogen, this method of detecting coagulation is frequently used. Along with other procoagulants like thrombin and factor X, fibrinogen is one of the main players in the process of blood clotting. The use of plasma as a specimen for coagulation tests is increasing as a result of this factor.

ELISA to Dominate Coagulation Markers Industry with 5.4% CAGR through 2033

The ELISA is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. The Human Coagulation Factor XII ELISA kit is intended for measuring coagulation factor XII levels in plasma. ELISA kits include recombinant monoclonal antibodies for specific and sensitive findings, as well as a single-wash technique that reduces test time to 90 minutes. The demand for ELISA kits is being driven by the shortened test time and effective outcomes.

Which Application is leading the Coagulation Markers Market?

Disseminated intravascular coagulation (DIC) is expected to dominate in the application segment with a CAGR of 6.7% from 2023 to 2033. Due to the rising incidence of cancer, it is projected that the market for diffused intravascular coagulation (DIC) would expand quickly over the forecast period. By 2040, the International Agency for Research on Cancer (IARC) projects that there will be 16.3 million cancer-related deaths and 27.5 million new cases worldwide. One of the main causes of disseminated intravascular coagulation (DIC) is cancer. Blood clotting proteins become overactive in a dangerous disorder known as diffused intravascular coagulation (DIC).

Which Segment is Expected to Lead the ‘Purpose’ Category Throughout the Forecast Period?

By purpose, clinical use segment is expected to continue leading the market over a CAGR of 6.0% throughout the projected timeframe. Coagulation tests have been shown to be clinically useful in the detection of cardiovascular illnesses and coagulation disorders, particularly DVT. Coagulant levels in the circulation increase dramatically in response to various illnesses, making it an important indicator for diagnosis. Because of their diagnostic usefulness, Coagulation tests are now widely used in clinical practice to guide antibiotic treatment and help clinical decision-making.

Which End User Is Leading The Coagulation Markers Market?

The hospitals have led the coagulation markers market as the leading end user with the CAGR of 7.4% in 2023 to 2033. Hospitals are the principal providers of acute care, serving a diverse variety of patients, including those suffering from severe chronic illnesses, coagulation problems, and other urgent circumstances. Coagulation tests are extremely useful in these conditions, assisting in the diagnosis, monitoring, and treatment of cardiovascular disorders. In these acute care circumstances, hospitals rely on coagulation tests to assist clinical decision-making, guide antibiotic treatment, and assess patient prognosis.

How Key Players Stay Competitive in the Coagulation Markers Industry?

The coagulation markers industry is highly competitive, with numerous players vying for market share. In such a scenario, key players must adopt effective strategies to stay ahead of the competition.

Key Strategies Adopted by the Players

  • Product Development

Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.

  • Strategic Alliances & Collaborations

Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.

  • Expansion into Emerging Markets

The coagulation markers sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.

  • Mergers and Acquisitions

Mergers and acquisitions are frequently used by key players in the coagulation markers business to consolidate their market position, increase their product portfolio, and gain access to new markets.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players in the Coagulation Markers Industry

  • Accuquik™ Test Kits
  • CTK Biotech, Inc.
  • Siemens Healthcare Private Limited
  • Quidel Corporation
  • Eurolyser Diagnostica GmbH
  • Goldsite Diagnostics Inc
  • Diazyme Laboratories, Inc
  • Hipro Biotechnology Co.,Ltd.

Key Developments in the Coagulation Markers Market:

  • On Jan. 20, 2023, Diazyme Laboratories, Inc. and Carolina Liquid Chemistries Corp. to reveal a partnership to increase the testing menu for the Diazyme DZ-Lite c270 tabletop clinical chemistry analyzer.

Segmentation Analysis of the Coagulation Markers Market

By Product:

  • D-dimer Assay
  • Fibrinogen Assay

By Sample Type:

  • Plasma
  • Whole Blood Sample
  • Other

By Technology:

  • Fluorescence Immunoassay
  • ELISA
  • Rapid Test
  • Particle-enhanced Immunoturbidimetric assay

By Application:

  • Deep Venous Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC)
  • Trauma
  • Others

By Purpose:

  • Clinical Use
  • Research Use Only

By End User:

  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

Which are the Key Asian Countries in the Coagulation Markers Market?

China, India, Japan dominate the market in Asia Pacific.

Which Industry is the Key Consumer of Coagulation Markers Market?

The healthcare sector is the main consumer of coagulation indicators.

What is the Growth Outlook of the United States in the Coagulation Markers Market?

The United States is predicted to record a CAGR of 5% from 2023 to 2033.

What is Current Market Valuation of Coagulation Markers Market?

The global coagulation markers market was valued at US$ 1.21 billion in 2023

How Big will be the Coagulation Markers Market by 2033?

The global coagulation markers market is projected to reach US$ 2.22 billion by 2033.

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Value Added Insights
  • 5. Market Background
  • 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033
  • 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
    • 9.1. D-dimer Assay
    • 9.2. Fibrinogen Assay
  • 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type
    • 10.1. Plasma
    • 10.2. Whole Blood Sample
    • 10.3. Other
  • 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Technology
    • 11.1. Fluorescence Immunoassay
    • 11.2. ELISA
    • 11.3. Rapid Test
    • 11.4. Particle-enhanced Immunoturbidimetric Assay
  • 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application
    • 12.1. Deep Venous Thrombosis (DVT)
    • 12.2. Pulmonary Embolism (PE)
    • 12.3. Disseminated Intravascular Coagulation (DIC)
    • 12.4. Trauma
    • 12.5. Others
  • 13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose
    • 13.1. Clinical Use
    • 13.2. Research Use Only
  • 14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
    • 14.1. Hospital
    • 14.2. Specialty Clinics
    • 14.3. Academic and Research Institutes
    • 14.4. Diagnostics Laboratories
  • 15. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
    • 15.1. North America
    • 15.2. Latin America
    • 15.3. Europe
    • 15.4. South Asia
    • 15.5. East Asia
    • 15.6. Oceania
    • 15.7. Middle East and Africa (Middle East & Africa)
  • 16. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 17. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 18. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 19. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 20. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 21. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 22. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 23. Market Structure Analysis
    • 24.1. Accuquik Test Kits
    • 24.2. CTK Biotech, Inc.
    • 24.3. Siemens Healthcare Private Limited
    • 24.4. Quidel Corporation
    • 24.5. Eurolyser Diagnostica GmbH
    • 24.6. Goldsite Diagnostics Inc
    • 24.7. Diazyme Laboratories, Inc
    • 24.8. Hipro Biotechnology Co.,Ltd.
  • 25. Assumptions and Acronyms Used
  • 26. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Coagulation Markers Market

Schedule a Call